Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

1.

Osteoporosis treatments and adverse events.

Solomon DH, Rekedal L, Cadarette SM.

Curr Opin Rheumatol. 2009 Jul;21(4):363-8. doi: 10.1097/BOR.0b013e32832ca433. Review.

PMID:
19412101
2.
3.

Bisphosphonate adverse effects, lessons from large databases.

Abrahamsen B.

Curr Opin Rheumatol. 2010 Jul;22(4):404-9. doi: 10.1097/BOR.0b013e32833ad677. Review.

PMID:
20473174
4.

Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back.

Salari P, Abdollahi M.

J Pharm Pharm Sci. 2012;15(2):305-17. Review.

5.

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.

Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D, Grbic J, Jontell M, Landesberg R, Laslop A, Wollenhaupt M, Papapoulos S, Sezer O, Sprafka M, Reginster JY.

Bone. 2008 May;42(5):841-7. doi: 10.1016/j.bone.2008.01.003. Epub 2008 Jan 18. Review.

PMID:
18314405
6.

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

Mavrokokki T, Cheng A, Stein B, Goss A.

J Oral Maxillofac Surg. 2007 Mar;65(3):415-23.

PMID:
17307586
7.

[Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review].

Capsoni F.

Reumatismo. 2008 Jan-Mar;60(1):6-13. Review. Italian.

8.

Long-term use of bisphosphonates in osteoporosis.

Watts NB, Diab DL.

J Clin Endocrinol Metab. 2010 Apr;95(4):1555-65. doi: 10.1210/jc.2009-1947. Epub 2010 Feb 19. Review.

PMID:
20173017
9.

Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.

King AE, Umland EM.

Pharmacotherapy. 2008 May;28(5):667-77. doi: 10.1592/phco.28.5.667. Review.

PMID:
18447663
10.

Bisphosphonate associated osteonecrosis of the jaw.

Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Lentle B, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Mardini MA, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, Ste-Marie LG, Brown J, Evans AW, Rios L, Compston JE; Canadian Taskforce on Osteonecrosis of the Jaw.

J Rheumatol. 2009 Mar;36(3):478-90. doi: 10.3899/jrheum.080759. Review.

PMID:
19286860
11.

Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management.

Wimalawansa SJ.

Expert Opin Drug Saf. 2008 Jul;7(4):491-512. doi: 10.1517/14740338.7.4.491 . Review.

PMID:
18613812
12.

Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonates.

Gebara SN, Moubayed H.

Am J Health Syst Pharm. 2009 Sep 1;66(17):1541-7. doi: 10.2146/ajhp080251. Review.

PMID:
19710437
13.

Update on osteoporosis treatment. Should you stay on bisphosphonate drugs long-term?

[No authors listed]

Harv Womens Health Watch. 2012 Aug;19(12):6. No abstract available.

PMID:
23033551
14.

Safety profile of intravenous bisphosphonates.

Mehrotra B.

Semin Oncol. 2007 Dec;34(6 Suppl 4):S24-7. Review.

PMID:
18068487
15.

[Osteonecrosis of the jaw and bisphophonates in oncology].

Facon T, Bensadoun RJ, Blanc JL, Confavreux C, Gourmet R, Maes JM, Penel G, Vieillard MH, Woeller A.

Bull Cancer. 2008 Apr;95(4):413-8. doi: 10.1684/bdc.2008.0617. Review. French.

16.

Safety of bisphosphonates.

Orozco C, Maalouf NM.

Rheum Dis Clin North Am. 2012 Nov;38(4):681-705. doi: 10.1016/j.rdc.2012.09.001. Review.

PMID:
23137577
17.

Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development.

Ruggiero SL.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):13-8. doi: 10.1016/j.joms.2008.10.005.

PMID:
19371810
18.

Current knowledge and future directions on bisphosphonate-related osteonecrosis of the jaw in cancer patients.

Adamo V, Caristi N, Saccà MM, Ferraro G, Arcanà C, Maisano R, Santini D, Tonini G.

Expert Opin Pharmacother. 2008 Jun;9(8):1351-61. doi: 10.1517/14656566.9.8.1351 . Review.

PMID:
18473709
19.

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.

McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM.

Am J Med. 2013 Jan;126(1):13-20. doi: 10.1016/j.amjmed.2012.06.023. Epub 2012 Nov 20. Review.

PMID:
23177553
20.

Bisphosphonates and osteonecrosis of the jaws.

Mariotti A.

J Dent Educ. 2008 Aug;72(8):919-29. Review.

Supplemental Content

Support Center